Oxidative stress and atherosclerosis

Current Atherosclerosis Reports

Volumn 7, Issue 3, 2005, Pages 242-248

  Schulze, P Christian ^b   Lee, Richard T ^a  

^a Partners Research Facility   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; ATHEROSCLEROSIS; DISEASE COURSE; ENDOTHELIUM; HUMAN; HYPERTENSION; LIPID OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW;

EID: 20444412299     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-005-0013-5     Document Type: Review

References (50)

1. Lefkowitz RJ, Willerson JT: Prospects for cardiovascular research. JAMA 2001, 285:581-587.
2. Libby P, Schwartz D, Brogi E, et al.: A cascade model for restenosis A special case of atherosclerosis progression. Circulation 1992, 86:III47-III52.
3. Libby P: Inflammation in atherosclerosis. Nature 2002, 420:868-874.
4. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
5. Stocker R, Keaney JF Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
6. Siess H: Oxidative Stress: Oxidants and Antioxidants. London: Academic Press; 1991.
7. Wendel A: Measurement of in vivo lipid peroxidation and toxicological significance. Free Radical Biol Med 1987, 3:355-358.
8. Halliwell B, Gutteridge J: Free Radicals in Biology and Medicine. New York: Oxford University Press; 1999.
9. Meyer B: Nitric Oxide. Berlin: Springer; 2000.
10. Griendling KK: Novel NAD(P)H oxidases in the cardiovascular system. Heart 2004, 90:491-493.
11. Lassegue B, Sorescu D, Szocs K, et al.: Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001, 88:888-894.
12. Patterson C, Ruef J, Madamanchi NR, et al.: Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 1999, 274:19814-19822.
13. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R: Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 1997, 96:2361-2367.
14. De Keulenaer GW, Alexander RW, Ushio-Fukai M, et al.: Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem 11998, 329(Pt 3):653-657.
15. De Keulenaer GW, Chappell DC, Ishizaka N, et al.: Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998, 82:1094-1101.
16. Szocs K, Lassegue B, Sorescu D, et al.: Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002, 22:21-27.
17. Barry-Lane PA, Patterson C, van der Merwe M, et al.: p47phox is required for atherosclerotic lesion progression in ApoE(- /-) mice. J Clin Invest 2001, 108:1513-1522.
18. Nishikawa T, Edelstein D, Du XL, et al.: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
19. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
20. Harrison D, Griendling KK, Landmesser U, et al.: Role of oxidative stress in atherosclerosis. Am J Cardiol 2003, 91:7A-11A.
21. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993, 91:2546-2551.
22. Cardillo C, Kilcoyne CM, Cannon RO 3rd, et al.: Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997, 30:57-63.
23. Spiekermann S, Landmesser U, Dikalov S, et al.: Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2003, 107:1383-1389.
24. Landmesser U, Dikalov S, Price SR, et al.: Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003, 111:1201-1209.
25. Fujii J, Ikeda Y: Advances in our understanding of peroxi-redoxin, a multifunctional, mammalian redox protein. Redox Rep 2002, 7:123-130.
26. Holmgren A: Thioredoxin. Annu Rev Biochem 1985, 54:237-271.
27. Nishiyama A, Masutani H, Nakamura H, et al.: Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 2001, 52:29-33.
28. Schulze PC, Yoshioka J, Takahashi T, et al.: Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 2004, 279:30369-30374.
29. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, et al.: Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J 2002, 21:1695-1703.
30. Leopold JA, Zhang YY, Scribner AW, et al.: Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler Thromb Vasc Biol 2003, 23:411-417.
31. Sundaresan M, Yu ZX, Ferrans VJ, et al.: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
32. Schulze PC, De Keulenaer GW, Yoshioka L et al.: Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res 2002, 91:689-695.
33. Pimentel DR, Amin JK, Xiao L, et al.: Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 2001, 89:453-460.
34. Shih NL, Cheng TH, Loh SH, et al.: Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes. Biochem Biophys Res Commun 2001, 283:143-148.
35. Xie Z, Kometiani P, Liu J, et al.: Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 1999, 274:19323-19328.
36. Rosen P, Nawroth PP, King G, et al.: The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001, 17:189-212.
37. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979, 76:333-337.
38. Zhao SP, Xu DY: Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells. Clin Chim Acta 2000, 296:121-133.
39. Auge N, Garcia V, Maupas-Schwalm F, et al.: Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol 2002, 22:1990-1995.
40. Takaku M, Wada Y, Jinnouchi K, et al.: An in vitro coculture model of transmigrant monocytes and foam cell formation. Arterioscler Thromb Vasc Biol 1999, 19:2330-2339.
41. Zettler ME, Prociuk MA, Austria JA, et al.: OxLDL stimulates cell proliferation through a general induction of cell cycle proteins. Am J Physiol Heart Circ Physiol 2003, 284: H644-H653.
42. Heitzer T, Krohn K, Albers S, Meinertz T: Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 2000, 43:1435-1438.
43. Grote K, Flach I, Luchtefeld M, et al.: Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003, 92:e80-e86.
44. Landmesser U, Cai H, Dikalov S, et al.: Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40:511-515.
45. Rey FE, Cifuentes ME, Kiarash A, et al.: Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 2001, 89:408-414.
46. Gregg D, Rauscher FM, Goldschmidt-Clermont PJ: Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol Cell Physiol 2003, 285:C723-C734.
47. Hink U, Li H, Mollnau H, et al.: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001, 88:E14-E22.
48. Mertens A, Verhamme P, Bielicki JK, et al.: Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003, 107:1640-1646.
49. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
50. Jacobson GM, Dourron HM, Liu J, et al.: Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res 2003, 92:637-643.